Medtronic

MDT | Continued stock growth - Timeframe: Weekly - Trade type: Buy stop order - Price: 84.03 - Take Profit: Open - Stop Loss: 81.49 (-3.00 %) Idea: Long on a breakout above last week's high - bullish momentum continuation. Entry: Buy stop above last week’s high. Stop-loss: Below the low of the same candle. If the weekly candle closes below this level, the trade is invalidated. Take Profit: Trailing stop following the lows of new weekly candles.

Bullish potential detected for MDT Entry conditions: (i) higher share price for NYSE:MDT along with swing up of indicators such as DMI/RSI, and (ii) observation of market reaction around the potential support/resistance line of $83.85 from the open of 23rd April. Depending on risk tolerance, the stop loss for the trade would be: (i) below the rising 15 day EMA (currently $81.84), or (ii) below the rising 50 day SMA (currently $79.33), or (ii) below the prior support/resistance line of $78.17 (from the open of 20th May).

MDT | The time to go long has come - Timeframe: Weekly - Trade type: Buy stop order - Price: 82.48 - Take Profit: Open - Stop Loss: 78.30 (-5.10 %) Idea: Long on a breakout above last week's high - bullish momentum continuation. Entry: Buy stop above last week’s high. Stop-loss: Below the low of the same candle. If the weekly candle closes below this level, the trade is invalidated. Take Profit: Trailing stop following the lows of new weekly candles.

Can a Medical Giant Transform Into a Growth Story?Medtronic has demonstrated significant momentum entering 2026, with its recent 23% share price appreciation reflecting fundamental improvements rather than speculative enthusiasm. The company delivered strong fiscal Q2 2026 results with revenue reaching approximately $9 billion, up 6.6% year-over-year, while adjusted earnings per share rose 8% to $1.36, surpassing both internal projections and analyst expectations. Most notably, cardiovascular revenue surged 10.8% to roughly $3.4 billion, markin

MDT Medtronic plc Options Ahead of Earnings If you haven`t bought the dip on MDT: Now analyzing the options chain and the chart patterns of MDT Medtronic plc prior to the earnings report this week, I would consider purchasing the 85usd strike price Calls with an expiration date of 2024-8-23, for a premium of approximately $1.32. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.

Medtronic leverages AI to enhance medical device development Medtronic Plc, a leading global medical device manufacturer, increasingly integrates artificial intelligence (AI) into its operations to enhance business efficiency and spearhead new developments. The company has positioned AI as a central element of its research and development strategy, employing machine learning algorithms to expedite the design and testing phases of new medical devices. The application of such AI solutions spans various functions, from optimising materials and device geom

Medtronic Beats Fourth-Quarter Estimates But Shares Down 2.44%Medtronic ( NYSE:MDT ), a health tech firm, has beat Wall Street estimates for quarterly profit and revenue in Q4 due to a pickup in surgical volumes at hospitals. The company's financial performance has grown due to a resurgence in demand as people, especially older adults, opted for medical procedures deferred during the COVID-19 pandemic. Medtronic forecasts fiscal 2025 adjusted per-share profit in the range of $5.40 to $5.50, with its midpoint in line with analysts' average estimate of $5.45

MDT Medtronic plc Options Ahead of Earnings If you haven`t bought the previous dip in MDT: Then analyzing the options chain and the chart patterns of MDT Medtronic plc prior to the earnings report this week, I would consider purchasing the 75usd strike price at the money Calls with an expiration date of 2023-11-24, for a premium of approximately $1.24. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.

MDT some upside action expected In case a dividend gap occurs early morning I will load up the paper for 15-20% upside mov.

MDT Medtronic Options Ahead Of Earnings Looking at the MDT Medtronic options chain ahead of earnings , i would buy the $82.5 strike price Calls with 2023-1-20 expiration date for about $2.93 premium. If the options turn out to be profitable Before the earnings release, i would sell at least 50%. Looking forward to read your opinion about it.

Medtronic - C Wave in upgoing Zigzag. MDT Goals 199, 190, 185. Invalidation at 230. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of

by Rykin_Capital

Medtronic & its 100sma The chart speaks for itself. 100sma has been held and tested multiple times. RSI has not gone below 35 RSI. Giving it a little wiggle room makes sense to avoid getting stopped out. The ATR (average true range) is 2 points. So a stop below $127 could potentially provide enough room.

by dorfmanmaster

Medtronic Getting Organized NYSE:MDT could be setting up for a breakout. MACD looks good and the price looks like it is gathering strength near the top of the triangle.

by TechnicallyCorrect

MDT burning off a little heat As I said in my previous post I didn't think MDT should be moving so fast. We had a nice run up but all good things need to take a break. Momentum is still bullish.

Piggyback the profiteers After some conversation with a young single mom and what she goes through to get her and her 2 yr old diabetes meds @ $13hr...f to the big pharma and f to the health care that does not cover such a life saving drug. It's not a conspiracy...it's a cultural failure to recognize how far we have come in such a short time. Some will call it profiteering...sure but it's also about what is done with those profits...what could be done. So I'm in on medtronic with the mission to take their pillaging and

mid term medtronic long. My idea in medtronic.

Using $TRXC info to guide $TMDI decision NASDAQ:TMDI AMEX:TRXC These symbols have been on a similar path throughout the year. From November to the beginning of January, $TRXC price action lagged a few days behind $TMDI. Since January $TMDI appears to be the follower. Watching price action of $TRXC when it reaches the yellow ellipse may give us an idea of how $TMDI will eventually exit this channel. May be a good spot for a short-term swing trade. Thanks for looking!

by excitedOil3295

Buy at Support Strong Support

Bull Flag&Breakout For Medtronic Plc Just Another Reason To Long Medtronic Plc has recently agreed to acquire all outstanding shares of spinal surgery device maker, Medicrea at €7.00/share, representing a 22% premium over Friday's closing price. This merger and acquisition has driven the share price to move up as well as giving the stock a promising future amidst the advent of second wave of the pandemic which most of the analysts foresee the economy to be worse than before. Key Trading Plan: Since the price has broken the trend line, wait for pull back

Medtronic PLC: MDT Watchlist Price moving along with 20MA Price narrowing Watch for break of the upper trendline

Medical devices will win Healthcare has been a leader YTD, as it has the defensive nature and is gaining momentum on the spread and containment of the COVID. Also, negative sentiment of the healthcare sector regarding the opioid crisis (which seems like a long time ago now), and politicians creating regulations for insurance reform; has now subsided. Inside the XLV, IHI (medical devices) and IBB (Biotechnology) have been outperforming, and will likely continue to do so. The 3 most important holdings of the ETF will b

by dorfmanmaster

Medtronic broke all time highs With the market down today, MDT doesn't care... It's breaking tested, heavy resistance at all time highs. Technicals look great as well. *Check chart for more info*

by dorfmanmaster

Is this stock worth owning?Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation product; insertable cardiac moni